High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings.

Charanpreet SinghSarthak WadheraUday YanamandraParathan KarunakaranNishant JindalSaloni Rani KumarNeha SainiAditya JandialArihant JainChandan DasGaurav PrakashAlka KhadwalShano NaseemReena DasNeelam VarmaSubhash VarmaPankaj MalhotraDeepesh P Lad

Published in: Acta oncologica (Stockholm, Sweden) (2022)

Keyphrases

high dose
liver failure
low dose
respiratory failure
stem cell transplantation
acute myeloid leukemia
bone marrow
high resolution
aortic dissection
drug induced
sickle cell disease
contrast enhanced
hepatitis b virus
magnetic resonance imaging
magnetic resonance
intensive care unit